Oramed Pharmaceuticals, Inc.
(NASDAQ : ORMP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.38%159.680.7%$1250.87m
LLYEli Lilly & Co. -1.68%327.361.1%$1087.51m
ABBVAbbVie, Inc. -1.27%138.511.9%$849.63m
PFEPfizer Inc. -2.21%42.140.9%$785.56m
BMYBristol-Myers Squibb Co. -0.58%69.841.0%$747.51m
MRKMerck & Co., Inc. -0.15%87.310.7%$696.62m
AZNAstraZeneca Plc 1.24%55.591.0%$390.97m
ALNYAlnylam Pharmaceuticals, Inc. -2.17%197.988.2%$219.95m
GSKGSK Plc 0.57%30.170.3%$209.70m
NVSNovartis AG -0.54%75.630.2%$199.82m
HZNPHorizon Therapeutics Plc -3.48%65.535.4%$182.14m
GBTGlobal Blood Therapeutics, Inc. 0.00%68.495.4%$178.81m
IDXXIDEXX Laboratories, Inc. -3.42%334.213.9%$178.04m
SRPTSarepta Therapeutics, Inc. -2.37%112.1012.4%$138.37m
AKROAkero Therapeutics, Inc. -0.53%39.050.0%$133.45m

Company Profile

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.